Ceftazidime
Ceftazidime for Injection, USP
Approved
Approval ID
112c5457-8d71-49f5-b531-9761d7d38c93
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 5, 2020
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 796852890
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ceftazidime
PRODUCT DETAILS
NDC Product Code25021-127
Application NumberANDA062640
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJune 6, 2018
Generic Nameceftazidime
INGREDIENTS (2)
ceftazidimeActive
Quantity: 1 g in 1 1
Code: 9M416Z9QNR
Classification: ACTIM
sodium carbonateInactive
Code: 45P3261C7T
Classification: IACT
ceftazidime
PRODUCT DETAILS
NDC Product Code25021-128
Application NumberANDA062640
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJune 6, 2018
Generic Nameceftazidime
INGREDIENTS (2)
ceftazidimeActive
Quantity: 2 g in 1 1
Code: 9M416Z9QNR
Classification: ACTIM
sodium carbonateInactive
Code: 45P3261C7T
Classification: IACT